{"nct_id":"NCT06953960","title":"A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-07-23","start_date_type":"ACTUAL","primary_completion_date":"2030-12","primary_completion_date_type":"ESTIMATED","completion_date":"2030-12","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["ABBV"]}